CD274 and invasive breast carcinoma: We identified 36, 44, and 81 genetic alterations, and 29, 89, and 81 miRNAs that are associated with CD274 upregulation in breast invasive carcinoma (BRCA), lung adenocarcinoma (LUAD), and skin cutaneous melanoma (SKCM), respectively.